The medical insurance company reported last month fourth-quarter earnings of $140.6 million, or $4.60 a share, up from year-earlier earnings of $102 million, or $3.32 a share."It seems like every quarter we talk about the same things for ProAssurance like strong earnings, favorable loss trends, stable pricing and well-managed strategic growth," Keefe, Bruyette & Woods analysts wrote in a Feb. 22 report. "The company continues to roll and has yet again generated another year with a double-digit ROE on top of a mountain of excess capital making it all that more impressive. We believe this stock should continue to climb toward the century mark, and it remains very attractive at current levels. We reiterate our Outperform rating." Forward Annual Dividend Yield: 1.1% Rated "A+ (Buy)" by TheStreet Ratings: The company's fourth-quarter gross profit margin increased from the prior year. In the fourth quarter, stockholders' net worth increased 16.62% from the previous year. TheStreet Ratings' price target is $116.98.
Kaydon The performance-critical products maker's Chief Financial Officer, Peter DeChants, announced earlier this month that he will retire next year. Timothy Heasley, former corporate controller of Gibraltar Industries, was named finance chief. "While KDN's higher margin legacy businesses should generate ample cash to pay down its debt levels, absent accretive acquisitions, we see few immediate revenue and earnings catalysts," KeyBanc Capital Markets analysts wrote in a Feb. 27 report. "While we believe KDN retains plenty of balance sheet firepower to fund acquisitions should they become available, we think the special dividend decision was driven by the lack of attractive candidates, a situation that could persist for the time being." Rated "B (Buy)" by TheStreet Ratings: The company's fourth-quarter gross profit margin decreased from the previous year. Kaydon is extremely liquid. Its Quick Ratio is 6.14, which shows the company can meet its short-term cash needs. In the fourth quarter, stockholders' net worth decreased 3.45% from the prior year. TheStreet Ratings' price target is $43.43.